De Dora Capital, Inc. Bio N Tech Se Transaction History
De Dora Capital, Inc.
- $341 Million
- Q3 2024
Shares
2 transactions
Others Institutions Holding BNTX
# of Institutions
358Shares Held
38.4MCall Options Held
2.45MPut Options Held
2.29M-
Baillie Gifford & CO8.31MShares$1.01 Billion0.75% of portfolio
-
Primecap Management CO Pasadena, CA4.52MShares$552 Million0.4% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.36MShares$532 Million2.05% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$231 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$221 Million0.88% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $29.6B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...